RE: BA.221 Jan 2022 18:39
Marik, I really dint think the lateral flow test is going to be a big earner for Avacta. That's just my opinion!.
It's all about early news from the therapeutic side of the business. Hopefully an update on ava6000 next week before they start the investor meetings.
That would make sense. And if ava6000 is positive there probably isn't a need to progress with the lift